EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation

Muhammad Yasir, Jinyoung Park, Wanjoo Chun iD

ACS Omega · 07.05.2024 · 9 (18) · 20338-20349

DOI: 10.1021/acsomega.4c00820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 23.04.2024. Verfasst von Muhammad Yasir und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.

ORCID-Profile: Wanjoo Chun

Förderung

  • Ministry of Education

Zitieren

APA

Yasir, M., Park, J., & Chun, W. (2024). Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation. ACS Omega, 9(18), 20338-20349. https://doi.org/10.1021/acsomega.4c00820

Vancouver

Yasir M, Park J, Chun W. Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation. ACS Omega. 2024;9(18):20338-20349. doi:10.1021/acsomega.4c00820

BibTeX
@article{Yasir2024,
  author = {Yasir, Muhammad and Park, Jinyoung and Chun, Wanjoo},
  title = {Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation},
  journal = {ACS Omega},
  year = {2024},
  volume = {9},
  number = {18},
  pages = {20338--20349},
  doi = {10.1021/acsomega.4c00820}
}
Kostenlos starten →